对患有肥胖相关喘的成年人进行减肥干预
Dinah Foer1, Erick Forno2, Fernando Holguin3
1Division of General Internal Medicine and Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.
The journal of allergy and clinical immunology. In practice
|December 30, 2023
概括
减肥可以通过减少呼吸道炎症和改善肺功能来改善成人喘结果. 有效的体重管理策略对于过敏学家和肺病学家在喘护理中考虑至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 肥胖医学 肥胖医学
背景情况:
- 肥胖是成人喘患者的重要并发症,增加了发病率和死亡率.
- 减肥干预措施通过各种机制为喘管理提供了潜在的好处.
- 有限的研究专门针对喘患者的减肥干预措施.
研究的目的:
- 审查减肥对喘的影响.
- 突出了解喘管理的减肥干预措施的重要性.
- 讨论这个领域的挑战和未来方向.
主要方法:
- 关于肥胖和喘的现有文献的综述.
- 对喘相关的减肥机制的分析.
- 讨论药理和非药理干预措施.
主要成果:
- 减肥可以通过减少呼吸道炎症和氧化应激来改善喘控制.
- 有效的体重管理需要针对个体目标的多学科支持.
- 葡萄糖皮质醇诱导的体重增加需要在喘患者中进行谨慎管理.
结论:
- 减肥干预措施对于改善成人喘结果至关重要.
- 需要进一步的研究来了解具体的机制和长期影响.
- 解决获得和成本方面的差异对于公平的护理至关重要.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
208
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
208
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Antiasthma Drugs: Leukotriene Modifiers
306
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
306


